THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 59,009 Value ($000) $476 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 59,009 Value ($000) $500 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 59,009 Value ($000) $529 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 59,009 Value ($000) $663 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 59,009 Value ($000) $509 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 59,009 Value ($000) $611 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 59,009 Value ($000) $640 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 59,009 Value ($000) $662 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 59,009 Value ($000) $598 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 59,009 Value ($000) $535 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 59,009 Value ($000) $564 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 59,009 Value ($000) $652 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 59,009 Value ($000) $437 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 59,009 Value ($000) $857 Avg Close $18.78 Range $14.46 - $22.74
Q1 2021
Shares 59,009 Value ($000) $1,204 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 59,009 Value ($000) $1,049 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 93,300 Value ($000) $1,379 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 93,300 Value ($000) $1,958 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 93,300 Value ($000) $2,156 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 93,300 Value ($000) $2,416 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 93,300 Value ($000) $1,817 Avg Close $20.20 Range $16.00 - $24.34
Q2 2019
Shares 93,300 Value ($000) $1,524 Avg Close $20.26 Range $15.18 - $25.38
Q1 2019
Shares 93,300 Value ($000) $2,115 Avg Close $25.36 Range $21.04 - $28.63
Q4 2018
Shares 93,300 Value ($000) $2,388 Avg Close $27.00 Range $21.70 - $35.48
Q3 2018
Shares 93,300 Value ($000) $3,048 Avg Close $27.25 Range $22.26 - $32.79
Q2 2018
Shares 93,300 Value ($000) $2,116 Avg Close $23.74 Range $21.27 - $26.00
Q1 2018
Shares 93,300 Value ($000) $2,263 Avg Close $27.46 Range $22.90 - $30.29
Q4 2017
Shares 93,300 Value ($000) $2,602 Avg Close $29.59 Range $25.20 - $35.90
Q3 2017
Shares 93,300 Value ($000) $3,195 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 93,300 Value ($000) $3,717 Avg Close $38.45 Range $34.85 - $43.44
Q1 2017
Shares 103,300 Value ($000) $3,804 Avg Close $31.95 Range $27.80 - $37.18
Q4 2016
Shares 103,300 Value ($000) $3,293 Avg Close $31.02 Range $24.54 - $38.92
Q3 2016
Shares 118,800 Value ($000) $4,305 Avg Close $27.84 Range $21.97 - $37.14
Q2 2016
Shares 265,700 Value ($000) $6,029 Avg Close $21.59 Range $15.00 - $24.76
Q1 2016
Shares 362,700 Value ($000) $6,819 Avg Close $16.36 Range $12.87 - $19.00
Q4 2015
Shares 408,600 Value ($000) $6,697 Avg Close $15.87 Range $10.56 - $19.75
Q3 2015
Shares 513,700 Value ($000) $5,646 Avg Close $12.73 Range $10.69 - $15.00
Q2 2015
Shares 486,700 Value ($000) $6,337 Avg Close $15.51 Range $12.52 - $18.92
Q1 2015
Shares 505,900 Value ($000) $8,777 Avg Close $18.33 Range $14.59 - $22.00
Q4 2014
Shares 574,400 Value ($000) $8,570 Avg Close $17.42 Range $13.11 - $24.06
Q3 2014
Shares 95,000 Value ($000) $2,190 Avg Close $29.01 Range $23.01 - $34.07
Q2 2014
Shares 101,228 Value ($000) $3,227 Avg Close $27.05 Range $14.75 - $35.67